Mirum Pharmaceuticals (MIRM)
(Delayed Data from NSDQ)
$24.46 USD
-0.03 (-0.12%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $24.43 -0.03 (-0.12%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/2/24 |
---|---|
Current Quarter | -0.37 |
EPS Last Quarter | -0.66 |
Last EPS Surprise | -94.12% |
ABR | 1.00 |
Earnings ESP
|
-35.27% |
---|---|
Current Year | -1.29 |
Next Year | 0.63 |
EPS (TTM) | -2.95 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 69.45M | 74.96M | 316.87M | 430.83M |
# of Estimates | 6 | 6 | 6 | 6 |
High Estimate | 72.90M | 79.40M | 325.50M | 483.20M |
Low Estimate | 63.70M | 71.80M | 308.89M | 398.78M |
Year ago Sales | 31.60M | 37.50M | 186.37M | 316.87M |
Year over Year Growth Est. | 119.78% | 99.89% | 70.02% | 35.96% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.37 | -0.33 | -1.29 | 0.63 |
# of Estimates | 6 | 6 | 7 | 6 |
Most Recent Consensus | 0.05 | 0.14 | 0.64 | 2.47 |
High Estimate | 0.05 | 0.14 | 0.64 | 2.47 |
Low Estimate | -0.73 | -0.76 | -2.48 | -1.52 |
Year ago EPS | -0.80 | -0.92 | -3.94 | -1.29 |
Year over Year Growth Est. | 53.75% | 64.13% | 67.26% | 148.63% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 0 |
Up Last 60 Days | 0 | 2 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 0 | 1 |
Down Last 60 Days | 4 | 2 | 4 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.37 | -0.33 | -1.29 | 0.63 |
7 Days Ago | -0.37 | -0.33 | -1.29 | 0.63 |
30 Days Ago | -0.30 | -0.24 | -1.12 | 1.08 |
60 Days Ago | -0.16 | -0.08 | -0.38 | 1.40 |
90 Days Ago | -0.10 | -0.02 | -0.18 | 1.67 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.51 | -0.50 | -1.57 | -0.54 |
Zacks Consensus Estimate | -0.37 | -0.33 | -1.29 | 0.63 |
Earnings ESP | -35.27% | -53.06% | -21.72% | -184.70% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.66 | -0.57 | -0.92 | -0.80 | NA |
Estimate | -0.34 | -0.64 | -0.81 | -0.96 | NA |
Difference | -0.32 | 0.07 | -0.11 | 0.16 | -0.05 |
Surprise | -94.12% | 10.94% | -13.58% | 16.67% | -20.02% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more